Entities/Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc.

Company
10 indicators

Net income

-69.39M

Not enough historical data

Diluted earnings per share (diluted EPS)

-1.03

Not enough historical data

Net cash flows from operating activities

-62.69M

Not enough historical data

Operating income

-78.06M

Not enough historical data

Operating expenses (excl. COGS)

78.06M

Not enough historical data

Research & development expense

58.44M

Not enough historical data

Financial

IndicatorLatest ValueYear

Total assets

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

937.13M2025

Total liabilities

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

33.25M2025

Purchases of property, plant and equipment

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

62K2025

Net cash provided by financing activities

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

374.95M2025